A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

CellFX marks another route for Afib ablation technology ...

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.

There are both clinical and economic implications, as payers have been discouraging ablation in this population, one expert ...

Microwave ablation (MWA) of colorectal liver metastases (CRLM) had low rates of failure and morbidity and warrants consideration as definitive treatment, authors of a large clinical review suggested.

The AVANT GUARD trial found that first-line pulsed field ablation (PFA) reduced atrial arrhythmia recurrence more than antiarrhythmic drugs in persistent atrial fibrillation. At 12 months, 56% of PFA ...

Two first-in-human studies presented at the Heart Rhythm Society meeting reported strong early safety and efficacy results for novel atrial fibrillation devices, including a nanosecond pulsed field ...